Purchase Order 75F40120P00651
Award Date 9/15/20
Potential Completion Date 11/12/25
Potential Value $432K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences to Illumina, Inc. for the purchase of an ILLUMINA NEXTSEQ2000 SEQUENCING SYSTEM. The $236,845.00 firm fixed price contract has a completion date of November 2, 2020. Illumina is a manufacturer of genetic and genomic analysis solutions, and has previously provided sequencing instruments, reagents, and services to support...
- The Department of Health and Human Services Food and Drug Administration awarded a $457,531.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the delivery of an ILLUMINA NEXTSEQ 2000 SEQUENCING SYSTEM, plus a preventative maintenance agreement, to be performed in Silver Spring, Maryland. This award does not have a set-aside designation. Illumina has a history of providing sequencing systems and related...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the provision of a NEXTSEQ 1000 Sequencing system. The $205,800.00 contract has a completion date of September 30, 2022 and was awarded on August 2, 2022. Illumina has previously received prime federal contracts from agencies such as the National Institutes of Health, Department of...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the provision of a next generation sequencer. The contract has a potential value of $100,980.00 and a completion date of August 28, 2020. Illumina has provided similar sequencing systems and consumables to support genomic research and diagnostics across various federal agencies such as the National...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of a "HIGH-THROUGHPUT DESKTOP SEQUENCER WITH DATA ANALYSIS SYSTEM" and has a ceiling value of $426,000.30. There is no set-aside designation for this contract. Illumina has previously provided a range of sequencing systems, reagents, and...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and related products. The contract is for the provision of a NEXTSEQ 1000 SEQUENCING SYSTEM, with a potential value of $142,100.00. The contract does not have a set-aside designation and is expected to be completed by April 14, 2025. Illumina has...
- This is a firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a NextSeq 500 Sequencing System, with a ceiling value of $292,000.00 and a completion date of September 23, 2016. The contract does not have a set-aside designation. Illumina has previously been awarded prime federal contracts and subcontracts by various...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for NEXTSEQ 500 comprehensive plan service maintenance for two NextSeq 500 sequencing systems at the FDA's location in Berwyn Heights, Maryland. The contract has a ceiling value of $265,801.32 and a period of performance through September 30, 2021. This contract does not have a...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $237,188.40 and no set-aside designation. Illumina will provide a range of sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq, along with associated reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of NextSeq 500 High Output Kits, with a ceiling value of $193,380.44 and a completion date of February 17, 2019. This delivery order appears to be part of a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of Medicine and Surgery,...